ArticleJournal of thoracic disease2026

Optimal duration of adjuvant immunotherapy after neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer: a systematic review and meta-analysis.

Zelong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.